09 January 2012 14:49 [Source: ICIS news]
The company plans to complete the addition of a new PVP production unit at the site by late 2013, it added.
"Over the next few years, Ashland expects steady growth [in PVP] driven by an industry need for formulation ingredients that improve the dissolution of poorly soluble drugs, and growth in emerging markets generated by increased demand for generic drug products and consumer demographics,” said Jeff Wolff, group vice-president of pharmaceutical and nutrition specialties at Ashland Specialty Ingredients.
No financial or capacity figures were disclosed.
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|